Cysteine and homocysteine as biomarker of various diseases

265Citations
Citations of this article
201Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cysteine and homocysteine (Hcy), both sulfur-containing amino acids (AAs), produced from methionine another sulfur-containing amino acid, which is converted to Hcy and further converted to cysteine. This article aims to highlight the link between cysteine and Hcy, and their mechanisms, important functions, play in the body and their role as a biomarker for various types of diseases. So that using cysteine and Hcy as a biomarker, we can prevent and diagnose many diseases. This review concluded that hyperhomocysteinemia (elevated levels of homocysteine) is considered as toxic for cells and is associated with different health problems. Hyperhomocysteinemia and low levels of cysteine associated with various diseases like cardiovascular diseases (CVD), ischemic stroke, neurological disorders, diabetes, cancer like lung and colorectal cancer, renal dysfunction-linked conditions, and vitiligo.

Cite

CITATION STYLE

APA

Rehman, T., Shabbir, M. A., Inam-Ur-Raheem, M., Manzoor, M. F., Ahmad, N., Liu, Z. W., … Aadil, R. M. (2020, September 1). Cysteine and homocysteine as biomarker of various diseases. Food Science and Nutrition. Wiley-Blackwell. https://doi.org/10.1002/fsn3.1818

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free